Lumos Health Advisory Second Cohort 2026

About

A 6-month incubation program designed for early-stage healthcare startups focusing on areas such as Oncology, Fertility, and Genomics, providing access to mentorship, infrastructural support, and fundraising opportunities to accelerate growth and market entry.

Benefits

• 💡Clinical Speed Scalability
  Access to clinical speed scalers to enhance operational efficiency.
• 🏗️ Infrastructural Support
  Provision of necessary infrastructure to facilitate startup growth.
• 💰Fundraising Access
  Access to fundraising opportunities through Anthill’s extensive investor network.
• 🤝One-on-One Mentoring
  Personalized mentoring sessions to refine business strategies and offerings.
• 🧪Clinical Trials Support
  Assistance with clinical trials and validation to expedite market entry.

Eligibility Criteria

• Startups must be in the areas of Oncology
• Fertility
• Maternal Health
• Genomics
• Innovative Diagnostics and Treatment
• Startups from outside India are welcome to apply.

Participation Commitments

• The program lasts for 6 months
• Startups are assessed for business and clinical success across India, Singapore, Israel, and the United States
• Startups must engage with mentors to shape their core offerings.

Target Region

Asia

Target Sector

Healthcare